Simplifying Global Compliance
U.S. FDA Pushes for More Blinding in Medtech Pivotal Trials
International Medical Device Regulatory Monitor
Devicemakers seeking regulatory approval in the U.S. are strongly urged to blind patients and investigators in pivotal clinical trials, when possible, according to final guidance issued by the Food and Drug Administration.
To View This Article:
Buy This Article Now
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing